Recurring nodular scleritis following inactivated vaccination for COVID‐19
Key Clinical Message Though COVID‐19 vaccination saved many lives all around the world, it has had many adverse effects including ophthalmologic side effects. It is important to report such adverse effects to provide timely diagnosis and management. Abstract Since the COVID‐19 global outbreak, many...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-06-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.7420 |
| _version_ | 1797791756742295552 |
|---|---|
| author | Alireza Peyman Mohsen Pourazizi Shakiba Dehghani Sarah Ghorbani |
| author_facet | Alireza Peyman Mohsen Pourazizi Shakiba Dehghani Sarah Ghorbani |
| author_sort | Alireza Peyman |
| collection | DOAJ |
| description | Key Clinical Message Though COVID‐19 vaccination saved many lives all around the world, it has had many adverse effects including ophthalmologic side effects. It is important to report such adverse effects to provide timely diagnosis and management. Abstract Since the COVID‐19 global outbreak, many types of vaccines have been introduced. These vaccines have been associated with some adverse effects including ocular manifestations. Herein, we report a case of a patient who developed nodular scleritis shortly after receiving the first and second doses of the inactivated COVID‐19 vaccine, Sinopharm. |
| first_indexed | 2024-03-13T02:23:18Z |
| format | Article |
| id | doaj.art-a4dd3b606d7943c4bcee8a43ca210475 |
| institution | Directory Open Access Journal |
| issn | 2050-0904 |
| language | English |
| last_indexed | 2024-03-13T02:23:18Z |
| publishDate | 2023-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | Clinical Case Reports |
| spelling | doaj.art-a4dd3b606d7943c4bcee8a43ca2104752023-06-30T07:34:07ZengWileyClinical Case Reports2050-09042023-06-01116n/an/a10.1002/ccr3.7420Recurring nodular scleritis following inactivated vaccination for COVID‐19Alireza Peyman0Mohsen Pourazizi1Shakiba Dehghani2Sarah Ghorbani3Department of Ophthalmology, Isfahan Eye Research Center Isfahan University of Medical Sciences Isfahan IranDepartment of Ophthalmology, Isfahan Eye Research Center Isfahan University of Medical Sciences Isfahan IranDepartment of Ophthalmology, Farabi Eye Hospital Tehran University of Medical Science Tehran IranDepartment of Ophthalmology, Isfahan Eye Research Center Isfahan University of Medical Sciences Isfahan IranKey Clinical Message Though COVID‐19 vaccination saved many lives all around the world, it has had many adverse effects including ophthalmologic side effects. It is important to report such adverse effects to provide timely diagnosis and management. Abstract Since the COVID‐19 global outbreak, many types of vaccines have been introduced. These vaccines have been associated with some adverse effects including ocular manifestations. Herein, we report a case of a patient who developed nodular scleritis shortly after receiving the first and second doses of the inactivated COVID‐19 vaccine, Sinopharm.https://doi.org/10.1002/ccr3.7420coronavirus disease‐2019COVID‐19 vaccinescleritisSinopharm |
| spellingShingle | Alireza Peyman Mohsen Pourazizi Shakiba Dehghani Sarah Ghorbani Recurring nodular scleritis following inactivated vaccination for COVID‐19 Clinical Case Reports coronavirus disease‐2019 COVID‐19 vaccine scleritis Sinopharm |
| title | Recurring nodular scleritis following inactivated vaccination for COVID‐19 |
| title_full | Recurring nodular scleritis following inactivated vaccination for COVID‐19 |
| title_fullStr | Recurring nodular scleritis following inactivated vaccination for COVID‐19 |
| title_full_unstemmed | Recurring nodular scleritis following inactivated vaccination for COVID‐19 |
| title_short | Recurring nodular scleritis following inactivated vaccination for COVID‐19 |
| title_sort | recurring nodular scleritis following inactivated vaccination for covid 19 |
| topic | coronavirus disease‐2019 COVID‐19 vaccine scleritis Sinopharm |
| url | https://doi.org/10.1002/ccr3.7420 |
| work_keys_str_mv | AT alirezapeyman recurringnodularscleritisfollowinginactivatedvaccinationforcovid19 AT mohsenpourazizi recurringnodularscleritisfollowinginactivatedvaccinationforcovid19 AT shakibadehghani recurringnodularscleritisfollowinginactivatedvaccinationforcovid19 AT sarahghorbani recurringnodularscleritisfollowinginactivatedvaccinationforcovid19 |